tiprankstipranks
Advertisement
Advertisement

Pfizer agrees to settle over 10,000 Zantac cancer suits, Bloomberg reports

Pfizer (PFE) has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, Bloomberg’s Jef Feeley reports, citing people familiar with the matter. The agreements cover cases in state courts across the U.S. but don’t completely resolve the company’s exposure to Zantac claims, according to the people. The deal is likely to reassure investors, who have seen other Zantac makers, including GSK (GSK) and Sanofi (SNY), sign settlements.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1